Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Torun's Clinic
The administration of a synthetic peptide (FOXO4-DRI = FOXO4-D-Retro-Inverso) to avoid the interaction between FOXO4 and p53 leads to a decrease of irradiated-induced senescent fibroblasts viability
Retrieved from: Memorial Sloan Kettering Cancer Center (MSKCC) (2022)
Contrast this with the peptides which faced major supply issues between 2023-2025 that compromised diabetic patient safety and led to higher prices, unequal access and a rise in fake medicines
In the Phase 3 TRIUMPH-4 trial, a new safety signal called dysesthesia (abnormal skin sensations like tingling or burning) appeared in up to 20.9% of patients on the highest dose
doi: 10.1007/s00125-013-3145-0 54 HoganAETobinAMAhernTCorriganMAGaoatsweGJacksonRet al
US$ 25.90
US$ 28.65
US$ 29.72
US$ 28.85
US$ 23.09
US$ 26.92
US$ 28.10
US$ 25.17
